Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer

This publication has 48 references indexed in Scilit:

• Concomitant low-dose cisplatin and three-dimensional conformal radiotherapy for locally advanced squamous cell carcinoma of the head and neck: Analysis of survival and toxicity
  Head & Neck, 2005
• Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14
  Journal of Clinical Oncology, 2005
• Epidemiology of head and neck cancer: Magnitude of the problem
  Cancer and Metastasis Reviews, 2005
• Dose–response relationships within the parotid gland after radiotherapy for head and neck cancer
  Radiotherapy and Oncology, 2004
• Meta-analysis of conventional versus altered fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC): Final analysis
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
• Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer
  Head & Neck, 2004
• Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer
  European Journal of Cancer, 2002
• No age limit for radical radiotherapy in head and neck tumours
  European Journal of Cancer, 1996
• The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors
  Radiotherapy and Oncology, 1995
• The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects
  Radiotherapy and Oncology, 1995